| 1. |
- van Bragt, JJMH, et al.
(författare)
-
Characteristics and treatment regimens across ERS SHARP severe asthma registries
- 2020
-
Ingår i: The European respiratory journal. - : European Respiratory Society (ERS). - 1399-3003 .- 0903-1936. ; 55:1
-
Tidskriftsartikel (refereegranskat)abstract
- Little is known about the characteristics and treatments of patients with severe asthma across Europe, but both are likely to vary. This is the first study in the European Respiratory Society Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) Clinical Research Collaboration and it is designed to explore these variations. Therefore, we aimed to compare characteristics of patients in European severe asthma registries and treatments before starting biologicals.This was a cross-sectional retrospective analysis of aggregated data from 11 national severe asthma registries that joined SHARP with established patient databases.Analysis of data from 3236 patients showed many differences in characteristics and lifestyle factors. Current smokers ranged from 0% (Poland and Sweden) to 9.5% (Belgium), mean body mass index ranged from 26.2 (Italy) to 30.6 kg·m−2 (the UK) and the largest difference in mean pre-bronchodilator forced expiratory volume in 1 s % predicted was 20.9% (the Netherlands versus Hungary). Before starting biologicals patients were treated differently between countries: mean inhaled corticosteroid dose ranged from 700 to 1335 µg·day−1 between those from Slovenia versus Poland when starting anti-interleukin (IL)-5 antibody and from 772 to 1344 µg·day−1 in those starting anti-IgE (Slovenia versus Spain). Maintenance oral corticosteroid use ranged from 21.0% (Belgium) to 63.0% (Sweden) and from 9.1% (Denmark) to 56.1% (the UK) in patients starting anti-IL-5 and anti-IgE, respectively.The severe asthmatic population in Europe is heterogeneous and differs in both clinical characteristics and treatment, often appearing not to comply with the current European Respiratory Society/American Thoracic Society guidelines definition of severe asthma. Treatment regimens before starting biologicals were different from inclusion criteria in clinical trials and varied between countries.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Arevalo-Martinez, D. L., et al.
(författare)
-
Ideas and perspectives: Land-ocean connectivity through groundwater
- 2023
-
Ingår i: Biogeosciences. - : Copernicus GmbH. - 1726-4170 .- 1726-4189. ; 20:3, s. 647-662
-
Tidskriftsartikel (refereegranskat)abstract
- For millennia, humans have gravitated towards coastlines for theirresource potential and as geopolitical centres for global trade. A basicrequirement ensuring water security for coastal communities relies on adelicate balance between the supply and demand of potable water. Theinteraction between freshwater and saltwater in coastal settings is,therefore, complicated by both natural and human-driven environmentalchanges at the land-sea interface. In particular, ongoing sea-level rise,warming and deoxygenation might exacerbate such perturbations. In thiscontext, an improved understanding of the nature and variability ofgroundwater fluxes across the land-sea continuum is timely yet remains outof reach. The flow of terrestrial groundwater across the coastal transitionzone and the extent of freshened groundwater below the present-dayseafloor are receiving increased attention in marine and coastal sciencesbecause they likely represent a significant yet highly uncertain componentof (bio)geochemical budgets and because of the emerging interest in thepotential use of offshore freshened groundwater as a resource. At the sametime, "reverse" groundwater flux from offshore to onshore is of prevalentsocio-economic interest, as terrestrial groundwater resources arecontinuously pressured by over-pumping and seawater intrusion in many coastalregions worldwide. An accurate assessment of the land-ocean connectivitythrough groundwater and its potential responses to future anthropogenicactivities and climate change will require a multidisciplinary approachcombining the expertise of geophysicists, hydrogeologists, (bio)geochemistsand modellers. Such joint activities will lay the scientific basis forbetter understanding the role of groundwater in societally relevant issuessuch as climate change, pollution and the environmental status of thecoastal oceans within the framework of the United Nations SustainableDevelopment Goals. Here, we present our perspectives on future researchdirections to better understand land-ocean connectivity through groundwater,including the spatial distributions of the essential hydrogeologicalparameters, highlighting technical and scientific developments and brieflydiscussing the societal relevance of that connectivity in rapidly changing coastal oceans.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
- Voronina, N, et al.
(författare)
-
The age of adult pilocytic astrocytoma cells
- 2021
-
Ingår i: Oncogene. - : Springer Science and Business Media LLC. - 1476-5594 .- 0950-9232. ; 40:16, s. 2830-2841
-
Tidskriftsartikel (refereegranskat)abstract
- Adult pilocytic astrocytomas (PAs) have been regarded as indistinguishable from pediatric PAs in terms of genome-wide expression and methylation patterns. It has been unclear whether adult PAs arise early in life and remain asymptomatic until adulthood, or whether they develop during adulthood. We sought to determine the age and origin of adult human PAs using two types of “marks” in the genomic DNA. First, we analyzed the DNA methylation patterns of adult and pediatric PAs to distinguish between PAs of different anatomic locations (n = 257 PA and control brain tissues). Second, we measured the concentration of nuclear bomb test-derived 14C in genomic DNA (n = 14 cases), which indicates the time point of the formation of human cell populations. Our data suggest that adult and pediatric PAs developing in the infratentorial brain are closely related and potentially develop from precursor cells early in life, whereas supratentorial PAs might show age and location-specific differences.
|
|
| 10. |
- Elsir, T., et al.
(författare)
-
PROX1 is a predictor of survival for gliomas WHO grade II
- 2011
-
Ingår i: British Journal of Cancer. - : Springer Science and Business Media LLC. - 0007-0920 .- 1532-1827. ; 104:11, s. 1747-1754
-
Tidskriftsartikel (refereegranskat)abstract
- Background:The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers that can predict prognosis in individual patients is of great clinical value. PROX1 is a transcription factor that has a critical role in the development of various organs. PROX1 has been ascribed both oncogenic and tumour suppressive functions in human cancers. We have recently shown that PROX1 may act as a diagnostic marker for high-grade gliomas. The aim of this study was to address the prognostic value of PROX1 in grade II gliomas.Methods:A total of 116 samples were evaluated for the presence of PROX1 protein. The number of immunopositive cells was used as a variable in survival analysis, together with established prognostic factors for this patient group.Results:Higher PROX1 protein was associated with poor outcome. In the multivariate analysis, PROX1 was identified as an independent factor for survival (P=0.024), together with the presence of mutated isocitrate dehydrogenase 1 R132H protein, and with combined losses of chromosomal arms 1p/19q in oligodendrocytic tumours.Conclusion:PROX1 is a novel predictor of survival for grade II gliomas.
|
|
